Apoptosis: Cell Death Chapter 5 PDF
Document Details
Uploaded by FresherEternity476
BAU
Tags
Related
- Pathology Colloquium 1 Slides 2022/2023 PDF
- Cell Injury, Cell Death & Adaptations PDF
- Cellular Injury II PDF - Wasit University 2024
- L'apoptose ou Mort Cellulaire Programmée - Université Joseph Fourier - PDF
- NURS 421 Altered Cellular & Tissue Biology Fall 2023 Class(1) PDF
- Pathophysiology Quiz 1 Study Guide PDF
Summary
This document provides an overview of apoptosis, including its definition, characteristics, and the mechanisms involved. The text elaborates on the process, its importance in various biological contexts, and highlights the fundamental roles of cellular processes, such as DNA fragmentation, and the function of various key molecules involved in apoptosis. This summary looks at the extrinsic and intrinsic pathways of apoptosis, including many of the proteins involved and their functions.
Full Transcript
**Chapter 5** - **Cell death** plays a crucial role in the development of animals and plants and continues into adulthood. - In a **healthy adult human**, billions of cells die every hour in the **bone marrow** and **intestine**. - **Tissues** do not shrink because **cell division**...
**Chapter 5** - **Cell death** plays a crucial role in the development of animals and plants and continues into adulthood. - In a **healthy adult human**, billions of cells die every hour in the **bone marrow** and **intestine**. - **Tissues** do not shrink because **cell division** balances **cell death** precisely. - These normal cell deaths are **suicides**. - **Cells** activate an **intracellular death program** and kill themselves in a controlled manner, a process called **programmed cell death**. **Definition** - **Apoptosis** is the most common form of **programmed cell death**. - The term originates from the Greek word meaning \"falling off.\" - The **cell surface** of apoptotic cells becomes chemically altered to allow **macrophages** to engulf them rapidly before their contents spill, avoiding a **damaging inflammatory response**. **Morphology** - Apoptotic cells exhibit distinct **morphological changes**: - Shrink and **condense**. - Collapse of the **cytoskeleton**. - Disassembly of the **nuclear envelope**. - Condensation and fragmentation of **nuclear chromatin**. - **Cell surface** often blebs and, if the cell is large, it breaks into **membrane-enclosed fragments** called **apoptotic bodies**. - The **surface** of the cell or apoptotic bodies becomes chemically altered. **Classical Examples of Apoptosis** - ***Animal development**:* - Sculpting **hands** and **feet**. - Regulating **cell numbers** in the developing **nervous system**. - Serving as a **quality control process** in the adaptive immune system development. - ***Metamorphosis**:* - Elimination of **unwanted cells**. - **Adult tissues**: - Removal of **abnormal**, **nonfunctional**, or **potentially dangerous cells**. - Elimination of **no longer needed cells**, such as **T** and **B lymphocytes** after resolving an infection. - Maintaining a ready supply of **short-lived neutrophils**. **Biochemistry** - **Biochemical changes** help identify apoptotic cells. - Cells undergoing apoptosis exhibit both **characteristic morphology** and **biochemical changes** that can serve as markers. 1. ***DNA Fragmentation:*** - During apoptosis, an **endonuclease** cleaves **chromosomal DNA** into fragments of distinctive sizes. - These cleavages occur in the **linker regions** between nucleosomes. - When analysed by **gel electrophoresis**, the fragments form a **ladder pattern**, characteristic of apoptotic cells. 2. ***Phosphatidylserine Flip**:* - The **negatively charged phospholipid phosphatidylserine**, normally found in the **inner leaflet** of the lipid bilayer, flips to the **outer leaflet** in apoptotic cells. - This serves as a **marker** for apoptotic cells and: - Signals **neighbouring cells** and **macrophages** to phagocytose the dying cell. - Blocks **inflammation** by inhibiting cytokine production in the **phagocytic cell**. 3. ***Loss of Mitochondrial Potential**:* - Apoptotic cells lose the **electric potential** across the inner mitochondrial membrane. - **Cytochrome C** is released from the **intermembrane space**, triggering further apoptotic signalling. **Apoptosis Machinery: Caspases (Overview)** - The **apoptosis machinery** relies on a family of proteases called **caspases**. - Caspases have a **cysteine** at their active site. - They cleave target proteins at specific **aspartic acid residues**. - **Caspases** are produced as inactive precursors called **procaspases**, which are activated by **proteolytic cleavage**. **Apoptosis: The Beginning** - **Healthy cells** continuously produce **procaspases**, ensuring the apoptosis machinery is always ready. - Apoptosis requires only a **trigger** to activate the machinery. - The activation of the first **procaspase** in the cascade involves: - **Initiator procaspases** that have a long prodomain containing a **caspase recruitment domain (CARD)**. - **CARD** facilitates the assembly with **adaptor proteins** into activation complexes when the cell receives an apoptotic signal. **Mechanism of Initiation** - Once incorporated into an **activation complex**: - **Initiator procaspases** are brought into proximity. - This proximity triggers their activation. - Activated initiator procaspases cleave one another, making the process **irreversible**.**Procaspase Activation** - ***Procaspases are split into two subunits:*** 1\. Large subunit 2. Small subunit - These subunits form a **heterodimer**, and two such dimers assemble into the **active tetramer**. **Executioner Caspase Activation** - The first caspases to be activated are the **initiator procaspases**. - These activate multiple **executioner procaspases**, creating an **amplifying chain reaction**. - **Executioner caspases** cleave various key proteins, including: 1\. Specific **cytosolic proteins**. 2. The **nuclear lamina**. - This leads to the **controlled death** of the cell. **Target Proteins** - **Executioner caspases** cleave a variety of target proteins, including: - **Nuclear lamina** - Proteins that keep **endonucleases** in their inactive form - **Cytoskeleton proteins** - **Cell-cell adhesion proteins** **Signalling Pathways** The two best understood signalling pathways that activate a caspase cascade leading to apoptosis in mammalian cells are: 1. **Extrinsic pathway** 2. **Intrinsic pathway** Each pathway uses its own initiator **procaspases** and activation complexes. **Extrinsic Pathway** - Triggered by **cell-surface Fas death receptors**. - ***Fas death receptors:*** - Belong to the **tumour necrosis factor (TNF) receptor family**. - ***Are homotrimeric transmembrane proteins with:*** - **Extracellular ligand-binding domain** - **Single transmembrane domain** - **Intracellular death domain**, required to activate the apoptotic program. **Fas Activation in the Extrinsic Pathway** - **Fas ligand** on the surface of a **killer lymphocyte** binds to **Fas death receptors** on the target cell. - The cytosolic tail of Fas recruits the adaptor protein **FADD** via their **death domains**. - Each **FADD protein** recruits an initiator procaspase (8, 10, or both) via their **death effector domains**, forming a **death-inducing signaling complex (DISC)**. - ***Within the DISC:*** - **Initiator procaspases** are brought into close proximity, activating them. - Activated procaspases cleave each other, stabilizing the active protease (now a caspase). - **Caspase-8** and **Caspase-10** then cleave and activate **executioner procaspases**, initiating a **caspase cascade** leading to apoptosis. **Inhibition of the Extrinsic Pathway** - Many cells produce **inhibitory proteins** to restrain the extrinsic pathway: **1. Extracellular Decoy Receptors**: - Have a **ligand-binding domain** but no **death domain**. - Bind death ligands but cannot activate apoptosis, competitively inhibiting death receptors. **2. Intracellular Blocking Proteins**: - Example: **FLIP**, which resembles an initiator procaspase but lacks a proteolytic domain. - FLIP competes with **procaspase-8** and **procaspase-10** for binding sites in the DISC, preventing their activation. These inhibitory mechanisms help prevent **inappropriate activation** of the extrinsic apoptosis pathway. **Intrinsic Pathway** - Triggered by **cellular stressors** such as: 1\. **Injury** 2. **DNA damage** 3. **Lack of oxygen** or nutrients **Release of Cytochrome C** - Cytochrome c, a component of the **electron transport chain**, is released from the **intermembrane space of mitochondria** during apoptosis. - **Fluorescence micrograph observations**: **1. *Control cells****:* - Transfected with a gene encoding **cytochrome-c-GFP** (green fluorescent protein). - Treated with a red dye that accumulates in mitochondria. - Overlapping green and red signals indicate **cytochrome-c-GFP** is in mitochondria. **2. *Apoptotic cells****:* - After ultraviolet light irradiation, **cytochrome-c-GFP** was released into the cytosol in apoptotic cells. - Cells at the bottom half of the micrograph released **cytochrome c**, while cells in the upper half retained it in mitochondria. **Mechanism of the Intrinsic Pathway** 1\. ***Cytochrome c release:*** - Once in the **cytosol**, cytochrome c binds to **Apaf1** (Apoptotic Protease Activating Factor-1). 2\. ***Apoptosome formation**:* - Cytochrome c binding causes **Apaf1** to oligomerize into a **wheel-like heptamer**, called the **apoptosome**. 3\. ***Recruitment of Initiator Procaspase-9**:* - **Apaf1** in the apoptosome recruit's **initiator procaspase-9**. 4\. ***Caspase cascade activation**:* - **Activated caspase-9** activates downstream **executioner procaspases**, leading to apoptosis. **Regulation Intrinsic pathway** **Bcl2** proteins **regulate** the **intrinsic pathway** of apoptosis. They **control** the release of **cytochrome c.** **Regulation of the Intrinsic Pathway** **Role of Bcl2 Proteins** 1. ***BH123 Proteins**:* - **Activated by apoptotic stimuli**. - Aggregate on the **outer mitochondrial membrane**. - Facilitate the release of **cytochrome c** and other proteins from the intermembrane space into the cytosol through an **unknown mechanism**. 2. ***Bcl2 Proteins (Anti-apoptotic)**:* - In the **absence of an apoptotic stimulus**, they bind to and inhibit **BH123 proteins** on the mitochondrial outer membrane. 3. ***BH3-only Proteins**:* - In the **presence of an apoptotic stimulus**, **BH3-only proteins** are activated. - Bind to anti-apoptotic **Bcl2 proteins**, preventing them from inhibiting **BH123 proteins**. - This allows **BH123 proteins** to aggregate on the mitochondrial outer membrane and promote the release of mitochondrial proteins into the cytosol. **Intrinsic pathway regulation** - **Bcl2** proteins are **not** the only ***intracellular regulators*** of apoptosis. - The ***IAPs (inhibitors of apoptosis)*** proteins also play an important part in ***suppressing apoptosis.*** - ***Intrinsic pathway regulation; inhibition: IAPs*** - ***IAPs*** are inhibitors of apoptosis **First discovered in viruses.** - Now it is known that it is **produced** in **many animals' cells.** **Proposed Model for the Roles of IAPs and Anti-IAPs in the Control of Apoptosis in Mammalian Cells** **In the Absence of an Apoptotic Stimulus** **1. *IAPs (Inhibitors of Apoptosis Proteins):*** - Prevent accidental apoptosis caused by the **spontaneous activation of procaspases**. - Located in the **cytosol**. - Bind to and inhibit any **spontaneously activated caspases**. **2. *Some IAPs function as ubiquitin ligases:*** - **Ubiquitylate** the caspases they bind to. - Mark caspases for **degradation in proteasomes** (not shown in the diagram). **Intrinsic pathway regulation; overcoming IAPs: anti-IAPs** **Role of Anti-IAP Proteins in the Intrinsic Pathway** 1\. ***Activation by an Apoptotic Stimulus**:* - When the intrinsic pathway is activated, proteins are released from the **mitochondrial intermembrane space**. 2\. ***Anti-IAP Proteins**:* - Bind to and block the **inhibitory activity** of IAPs. 3\. ***Cytochrome c Release**:* - Triggers the assembly of **apoptosomes**. 4\. ***Caspase Cascade Activation**:* - The apoptosome activates a **caspase cascade**, ultimately leading to **apoptosis**. **Extracellular Survival Factors Inhibit Apoptosis in various ways** **Three Ways Extracellular Survival Factors Can Inhibit Apoptosis** **(A) *Stimulation of Anti-apoptotic Gene Transcription*** 1. **Survival factors** suppress apoptosis by stimulating the transcription of genes encoding **anti-apoptotic Bcl2 proteins**, such as: 1. **Bcl2** itself. 2. **Bcl-XL**. **(B) *Activation of Serine/Threonine Protein Kinase Akt*** 1. ***Akt activation**:* - Many survival factors activate the **serine/threonine protein kinase Akt**. - Akt phosphorylates and inactivates **Bad**, a BH3-only pro-apoptotic protein. ***Effect of Bad phosphorylation**:* - When **Bad is not phosphorylated**, it promotes apoptosis by: - Binding to and inhibiting **Bcl2**. - When **Bad is phosphorylated**, it dissociates, freeing **Bcl2** to suppress apoptosis. **Other Akt actions**: - Akt suppresses apoptosis by phosphorylating and inactivating **gene regulatory proteins** of the **Fork head family**, which stimulate transcription of pro-apoptotic genes (details not shown). **(C) *Regulation in Drosophila*** - Some survival factors in **Drosophila** inhibit apoptosis by stimulating the **phosphorylation of the anti-IAP protein Hid**. - ***Hid regulation**:* - When **not phosphorylated**, Hid promotes cell death by inhibiting **IAPs**. - When **phosphorylated**, hid no longer inhibits IAPs, which then become active and block apoptosis. **Either Excessive or insufficient apoptosis can contribute to disease** **Disorders Associated with Abnormal Apoptosis** **1. *Excessive Apoptosis*** **Examples**: - **Heart attacks and strokes**: - In acute conditions, many cells die due to necrosis caused by **ischemia** (inadequate blood supply). - However, some less-affected cells die by apoptosis. - ***Future hope**:* - Drugs such as **caspase inhibitors** that block apoptosis might save cells in these conditions. **2. *Insufficient Apoptosis*** - ***Causes**:* - **Mutations in genes** encoding the Fas death receptor or the Fas ligand prevent the normal death of some lymphocytes. - ***Effects**:* - Causes these cells to **accumulate in excessive numbers** in the spleen and lymph glands. - Leads to **autoimmune diseases**, where lymphocytes react against the individual's tissues. **3. *Role in Tumours and Cancer*** - **Decreased apoptosis** is a significant factor in tumor development as cancer cells often regulate the apoptotic program abnormally. - ***Role of Bcl2 gene**:* - First identified in a common form of **lymphocyte cancer** in humans. - A chromosomal translocation causes excessive production of the **Bcl2 protein**. - Increased Bcl2 levels protect lymphocytes from apoptosis, resulting in **B-cell lymphoma**. - ***Impact of high Bcl2 levels**:* - Prolongs cell survival and increases cell numbers by inhibiting apoptosis. - Decreases sensitivity to anticancer drugs that kill cancer cells by inducing apoptosis. **4. *p53 Mutation in Cancer*** - ***Role of p53**:* - A tumour suppressor protein that promotes apoptosis or cell-cycle arrest in response to DNA damage. - Its loss allows cells to survive and proliferate even with DNA damage. - This leads to the accumulation of more mutations, making cancer cells more malignant. - ***Impact on treatment**:* - Many anticancer drugs rely on a **p53-dependent mechanism** to induce apoptosis. - The **loss of p53 function** makes cancer cells less sensitive to these drugs. **Summary** **Overview of Programmed Cell Death (Apoptosis):** 1. ***Definition and Purpose:*** - Cells can activate a death program to kill themselves in a controlled way, termed **programmed cell death**. - This process allows elimination of irreversibly damaged or unnecessary cells, benefiting the organism. 2. ***Characteristics of Apoptosis:*** - Cells **shrink**, become **dense**, and **frequently fragment**. - Neighbouring cells or macrophages **rapidly phagocytose** the fragments, preventing cytoplasmic content leakage. 3. ***Role of Caspases:*** - Apoptosis relies on **proteolytic enzymes** called **caspases** to destroy intracellular components. - Caspases are present as inactive **procaspases** in animal cells. - **Initiator procaspases** are activated by bringing them into **activation complexes**. - Activated initiator procaspases cleave **executioner procaspases**, triggering a cascade of **irreversible proteolysis**. **Pathways for Caspase Activation:** 1. ***Extrinsic Pathway:*** - Activated by **extracellular ligands** binding to **cell-surface death receptors**. - Death receptors recruit **procaspases-8 and -10** via **adaptor proteins** to form the **DISC** (death-inducing signalling complex). 2. ***Intrinsic Pathway:*** - Triggered by **intracellular stress signals**. - **Cytochrome c**, released from the **mitochondrial membrane**, activates **Apaf1**, which forms an **apoptosome**. - The apoptosome recruits and activates **procaspase-9**. **Regulation of Apoptosis:** 1. ***Role of Bcl2 Proteins:*** - Extracellular signal proteins and intracellular **Bcl2 proteins** and **IAP proteins** tightly regulate apoptosis. - These proteins ensure cells only undergo apoptosis when it benefits the organism. 2. ***Pro-apoptotic vs Anti-apoptotic:*** - **Anti-apoptotic Bcl2 proteins** prevent mitochondrial intermembrane release. - **Pro-apoptotic Bcl2 proteins** promote cytochrome c release, activating caspases and facilitating apoptosis.